The role of toll-like receptors in osteoclastogenesis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yim, Mijung | - |
dc.date.available | 2021-02-22T05:21:13Z | - |
dc.date.issued | 2020-11 | - |
dc.identifier.issn | 2287-6375 | - |
dc.identifier.issn | 2287-7029 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/1053 | - |
dc.description.abstract | Bone homeostasis is maintained by a balance in the levels of osteoclast and osteoblast activity. Osteoclasts are bone-resorbing cells and have been shown to act as key players in various osteolytic diseases. Osteoclasts differentiate from monocyte/macrophage lineage cells in the presence of receptor activator of nuclear factor-κB ligand and macrophage colony-stimulating factor. Osteoblasts support osteoclastogenesis by producing several osteoclast differentiation factors. Toll-like receptors (TLRs) are members of the pattern recognition receptor family that are involved in recognizing pathogen-associated molecular patterns and damage-associated molecular patterns in response to pathogen infection. TLRs regulate osteoclastogenesis and bone resorption through either the myeloid differentiation primary response 88 or the Toll/interleukin-1 receptor domain-containing adapter-inducing interferon-β signaling pathways. Since osteoclasts play a central role in the progression of osteolytic diseases, extensive research focusing on TLR downstream signaling in these cells should be conducted to advance the development of effective TLR modulators. In this review, we summarize the currently available information on the role of TLRs in osteoclast differentiation and osteolytic diseases. Copyright © 2020 The Korean Society for Bone and Mineral Research | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Korean Society for Bone and Mineral Research | - |
dc.title | The role of toll-like receptors in osteoclastogenesis | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.11005/JBM.2020.27.4.227 | - |
dc.identifier.scopusid | 2-s2.0-85098969514 | - |
dc.identifier.bibliographicCitation | Journal of Bone Metabolism, v.27, no.4, pp 227 - 235 | - |
dc.citation.title | Journal of Bone Metabolism | - |
dc.citation.volume | 27 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 227 | - |
dc.citation.endPage | 235 | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002654644 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Bone diseases · Osteoclasts · Osteolysis | - |
dc.identifier.url | https://www.e-jbm.org/journal/view.php?doi=10.11005/jbm.2020.27.4.227 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.